Your browser doesn't support javascript.
loading
Understanding the Radiobiology of Vestibular Schwannomas to Overcome Radiation Resistance.
Thielhelm, Torin P; Goncalves, Stefania; Welford, Scott M; Mellon, Eric A; Cohen, Erin R; Nourbakhsh, Aida; Fernandez-Valle, Cristina; Telischi, Fred; Ivan, Michael E; Dinh, Christine T.
Afiliação
  • Thielhelm TP; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Goncalves S; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Welford SM; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Mellon EA; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Cohen ER; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Nourbakhsh A; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Fernandez-Valle C; Burnett School of Biomedical Sciences, University of Central Florida College of Medicine, Orlando, FL 32816, USA.
  • Telischi F; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Ivan ME; Department of Neurological Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
  • Dinh CT; Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Cancers (Basel) ; 13(18)2021 Sep 12.
Article em En | MEDLINE | ID: mdl-34572805
ABSTRACT
Vestibular schwannomas (VS) are benign tumors arising from cranial nerve VIII that account for 8-10% of all intracranial tumors and are the most common tumors of the cerebellopontine angle. These tumors are typically managed with observation, radiation therapy, or microsurgical resection. Of the VS that are irradiated, there is a subset of tumors that are radioresistant and continue to grow; the mechanisms behind this phenomenon are not fully understood. In this review, the authors summarize how radiation causes cellular and DNA injury that can activate (1) checkpoints in the cell cycle to initiate cell cycle arrest and DNA repair and (2) key events that lead to cell death. In addition, we discuss the current knowledge of VS radiobiology and how it may contribute to clinical outcomes. A better understanding of VS radiobiology can help optimize existing treatment protocols and lead to new therapies to overcome radioresistance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article